Sigachi Share Price Target 2024-2030 Fundamentals & Quarterly Results

Sigachi Share Price Target 2024, 2025, 2026, 2027, 2028, 2029, 2030 Fundamentals & Quarterly Results – Sigachi Industries ltd was listed in the stock exchanges several years back as new to the stock exchanges securities exchange the company hasn’t created demand for its stock but the reputation built by the company based on that performance is increasing the share prices because it has stuck to what it knows best such as medicine production and retail under Pharma.

Latest Update – The net profit of Sigachi Industries Ltd grew by (20.96%) as compared to the net profit of the same period last year which was ₹13.16 Cr in Q1 2024-2025. When compared to the previous quarter’s results, Sigachi Industries Ltd. has experienced a decline of -12.5% in its net profits over the past three months.

Sigachi Overview

SIL (Sigachi Industries Ltd) has three multi locational facilities in Telangana and Gujarat and is among the largest manufacturers globally for Microcrystalline Cellulose.

Company Name	Sigachi Industries Ltd
Listed at	NSE & BSE
Head Office	229/1 & 90, 4th Floor, Kalyan Tulasiram Chambers, Madeenaguda, 500049
Board Of Directors	Mr.Rabindra Prasad Sinha Chairman Mr.Chidambarnathan Shanmuganathan Executive Vice Chairman Mr.Sarveswara Reddy Sanivarapu Independent Director Ms.Dhanalakshmi Guntaka Independent Director Ms.Bindu Vinodhan Independent Director Mr.Amit Raj Sinha Managing Director & CEO
Official Website	sigachi.com

Also Check Campus Share Price Target

Sigachi Business Profile

One of the main companies manufacturing and supplying MCC (cellulose based excipients) in the country is Sigachi Industries Limited with vast experience in the field of more than 30 years. Sigachi Industries Limited offers 59 different grades of MCC which have a particle size from 15 microns up to 250 microns today. HiCel, AceCel, CoatCel, GloCel, and BARETab are several of the brands through which its cellulose based products are marketed by the company, The Co.

Diverse End-use Application

MCC’s applications are diverse in the pharmaceutical, food, nutraceuticals, and cosmetic industries due to its non-reactive, free-flowing, and versatile nature. The key clients include Himalaya, Herballife Nutrition, Cipla, Lupin, wockhardt, Ipca etc.

Also Check Canara Bank Share Price Target

Manufacturing Capabilities

Co. owns three MCC manufacturing plants located in Hyderabad, Jhagadia, and Dahej. Their installed capacity and the extent to which they are utilized respectively are as follows –

Hyderabad – 6,400 MTPA – 92%
Jhagadia – 2,600 MTPA – 93%
Dahej – 4,800 MTPA – 96%

Also Check Samvardhana Motherson Share Price Target

Capacity Expansion

Increase the capacity of Dahej and Jhagadia by 3,600 MTPA and 3,600 MTPA respectively. Additionally, it intends to put up a new plant in Kurnool, thus bringing the total capacity of the company to 21,150 MTPA. For FY24, the anticipated capex is Rs.50 crs.

Also Check Wipro Share Price Target

Global Presence

Company supplies in over 50 countries worldwide including Australia USA South America UK Poland Italy Denmark China Colombia Bangladesh. The contributions of income are as follows in the year 2023; IUSA is 20%, Australia is 15%, Sweden is 12% and Egypt is 9%.

Also Check Wockhardt Share Price Target

Contract Manufacturing

The agreement between Co. and Gujarat Alkalies and Chemicals Limited (GACL) is for the purpose of operating and managing the manufacturing units belonging to the latter and for contract manufacture of sodium chlorate, stable bleaching powder and poly aluminum chloride.

Also Check Yes Bank Share Price Target

R & D

They invest a lot into R & D so as to increase their range of products as well as make it simple for them to produce product. The company has two R & D divisions and another two laboratories running.The Dahej R & D division laboratory is fully licensed by DSIR to carry out any research related operations.

Also Check Tata Elxsi Share Price Target

New Product & Subsidiaries

The company is planning on producing Croscarmellose Sodium (CCS) in FY24. It will be used in pharma industry to a larger extent.
By the end of FY23, the company Sigachi MENA FZCO will be one of its two subsidiaries in addition to Sigachi US Inc.

Also Check RBL Bank Share Price Target

Strategic Focus

1. This is a reflection of an increase in its concentration on manufacturing MCC, which is its core business.
2. Development of new pharmaceutical products.
3. The expansion of its operations into the food and nutrition industry has been enabled by the production of dry substances used in making sprays as well as micronutrient mixtures among other things.
4. Enhancing global footprint
5. Generics that have been branded by the Health Care Division and the OTC market.
6. Increasing the amount of Dahej production facilities.

Also Check Marksans Pharma Share Price Target

Sigachi Fundamentals & Quarterly Results

Terms	Value
Market Cap	₹ 1,988 Cr.
Current Price	₹ 60.4
High / Low	₹ 95.9 / 24.0
Stock P/E	34.8
Book Value	₹ 13.1
Dividend Yield	0.16 %
ROCE	17.2 %
ROE	16.4 %
Face Value	₹ 1.00
Debt to Equity	0.29
Debt Capacity	0.00
Debt Preceding Year	₹ 68.5 Cr.
Debt	₹ 123 Cr.
Reserves	₹ 397 Cr.
EPS	₹ 1.74
EPS Last Year	₹ 1.74
Pledged Percentage	21.7 %
FCF Previous Year	₹ -71.7 Cr.
EV/EBITDA	23.2
Industry P/E	29.3
PEG Ratio	1.41
Piotroski Score	3.00
Earnings Yield	3.74 %
Sales Growth (5 Years)	25.3 %

Also Check Union Bank Share Price Target

Sigachi Quarterly Results

	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Sales	66	73	78	82	69	72	85	99	111	104
Expenses	53	58	62	66	55	60	68	78	88	88
Operating Profit	13	15	16	16	14	12	16	21	23	16
OPM %	19%	20%	21%	20%	20%	17%	19%	22%	20%	16%
Other Income	1	2	2	2	1	2	2	1	2	7
Interest	0	0	0	1	1	1	1	2	2	3
Depreciation	1	1	1	2	2	2	2	3	3	3
Profit Before Tax	12	15	17	15	12	10	15	18	20	17
Tax %	22%	23%	23%	11%	20%	29%	26%	17%	18%	12%
Net Profit	10	12	13	14	10	7	11	15	16	15
EPS in Rs	0.31	0.38	0.42	0.44	0.32	0.24	0.35	0.49	0.50	0.46

CAGR Report

	10 Years	5 Years	3 Years	TTM/1 Year	Last Year
Compounded Sales Growth	%	25%	27%	32%	–
Compounded Profit Growth	%	25%	24%	31%	–
Stock Price CAGR	%	%	%	154%	–
Return on Equity	%	21%	19%	–	16%

Sigachi Shareholding Pattern

	Mar 2022	Mar 2023	Mar 2024
Promoters	48.48%	48.49%	45.43%
FIIs	0.23%	0.09%	2.06%
DIIs	2.92%	0.00%	0.00%
Public	48.37%	51.43%	52.51%
No. of Shareholders	98,638	86,576	137,506